Long-Stalled Legislation Aimed At Increasing Competition From Cheaper Generic Drugs To Finally Move Forward

House Energy and Commerce Committee Chairman Frank Pallone Jr. (D-N.J.) and Rep. Greg Walden (R-Ore.) have reached a key agreement over the measure. Aides in both parties said Democrats verbally agreed to make changes to one of the most prominent measures, known as the Creates Act, which cracks down on tactics drug companies use to delay the introduction of cheaper generic drugs.

from Kaiser Health News https://ift.tt/2YXK1Gy